1. Home
  2. SNTI vs BAOS Comparison

SNTI vs BAOS Comparison

Compare SNTI & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

BUY

Current Price

$0.19

Market Cap

10.4M

Sector

Health Care

ML Signal

BUY

Logo Baosheng Media Group Holdings

BAOS

Baosheng Media Group Holdings

HOLD

Current Price

$0.17

Market Cap

9.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNTI
BAOS
Founded
2016
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
9.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
SNTI
BAOS
Price
$0.19
$0.17
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $13.50
N/A
AVG Volume (30 Days)
★ 395.0K
240.1K
Earning Date
11-12-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 77.31
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$127.27
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.21
$0.16
52 Week High
$6.21
$3.82

Technical Indicators

Market Signals
Indicator
SNTI
BAOS
Relative Strength Index (RSI) 45.68 23.24
Support Level N/A N/A
Resistance Level $0.90 $0.26
Average True Range (ATR) 0.15 0.02
MACD -0.14 0.01
Stochastic Oscillator 0.00 7.74

Price Performance

Historical Comparison
SNTI
BAOS

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd is a China-based online marketing solution provider. The company provides internet marketing, short-video and V-log marketing, content production and operation, e-commerce marketing, data platform services, and AI technology-related services. It also offers customized marketing solutions and channel marketing services through partnerships with internet platforms such as Tencent, Alibaba, ByteDance, and Kuaishou.

Share on Social Networks: